This power point presentation has described role of biotechnology in management of diseases. This presentation also contains different biotechnological techniques for Treating, Diagnosing, preventing and understanding the disease.
Presented by- MD JAKIR HOSSAIN
Doctoral Research Scholar
Department of Agricultural Genetic Engineering ,
Faculty of Agricultural Sciences and Technologies,
Nigde Omer Halisdemir University, Turkey
E. Mail- mjakirbotru@gmail.com
this presentation deals with Molecular Ph(f)arming, and bio-safety issues related to it. This was presented by me in credit seminar in the division of Agricultural physics, IARI, New Delhi.
the sources used are duly acknowledged in the figures and slides.
Introduction
Ti plasmid
Agrobacterium tumefaciens
Ti plasmid structure
Overview of infection process
Ti plasmid derived vector systems
Cointegrate vectors
Binary vectors
Agrobacterium mediated transformation of explants
Conclusions
References
inroduction:Plant viruses are viruses that affect plants.
Pathogenic to higher plants.
. Harmless to human and other animals.
Reduce plant crop yield and quality of crops.
Some may be able to multiply within the bodies
Of aphids and nematodes.
History:Beijernick ( 1897) coined the latin name “VIRUS” meaning Poison. He studied plant juices and found they caused healthy plants to become sick.
Wendell Stanley (1935) crystallized sap from sick Tobacco plants. He discovered viruses were made of nucleic acids and proteins.
Geminivirus:one of the family of plant virus.
Currently over 360 species in this family, divided among 9 genera.
Diseases associated with this family include bright yellow mosaic , yellow mosaic, yellow mottle, leaf curling, stunting, streaks, reduced yields.
Ss circular dna diverge in both directions from a virion strand origin of replication (AMBISENSE).
Virus Classification:Group – Group II (ssDNA)
Order - Unassigned
Family - Geminiviridae
Genera – Becurtovirus Grablovirus
Begomovirus Mastrevirus
Capulavirus Topocuvirus
curtovirus Turncurtovirus
Eragrovirus
Structure: have Circular single-stranded DNA.
Genome is either in two segments.
The non-segmented genome is 2500-3000 nucleotides long, and the segmented genome is 4800-5600 nucleotides long.
The genome encodes for both structural and non-structural proteins.
In geminivirus, both segments must be transmitted to the host for a full systemic infection to occur.
Virion Sturcture:Geminivirus are non-enveloped, icosahedral virions that consists of a capsid.
The capsid is germinate, or twinned, and consists of 22 Capsomers.
The capsid is 30nm long and has a diameter of 18-20nm.
Symptoms:the time of infection, the virus strains and the presence of mixed infections.
Common symptoms are stunting, curling, and twisting of leaves.
Short internodes and stunted appearance , no apical growth caused by early infection.
Replication:Geminivirus encodes only a few proteins, thus they need to dependent host cell factors for replication.
These factors are DNA polymerase and repair polymerase to amplify their genome.
Replicate by a rolling circle mechanism like bacteriophages such as M13, and many plasmids.
Presented by- MD JAKIR HOSSAIN
Doctoral Research Scholar
Department of Agricultural Genetic Engineering ,
Faculty of Agricultural Sciences and Technologies,
Nigde Omer Halisdemir University, Turkey
E. Mail- mjakirbotru@gmail.com
this presentation deals with Molecular Ph(f)arming, and bio-safety issues related to it. This was presented by me in credit seminar in the division of Agricultural physics, IARI, New Delhi.
the sources used are duly acknowledged in the figures and slides.
Introduction
Ti plasmid
Agrobacterium tumefaciens
Ti plasmid structure
Overview of infection process
Ti plasmid derived vector systems
Cointegrate vectors
Binary vectors
Agrobacterium mediated transformation of explants
Conclusions
References
inroduction:Plant viruses are viruses that affect plants.
Pathogenic to higher plants.
. Harmless to human and other animals.
Reduce plant crop yield and quality of crops.
Some may be able to multiply within the bodies
Of aphids and nematodes.
History:Beijernick ( 1897) coined the latin name “VIRUS” meaning Poison. He studied plant juices and found they caused healthy plants to become sick.
Wendell Stanley (1935) crystallized sap from sick Tobacco plants. He discovered viruses were made of nucleic acids and proteins.
Geminivirus:one of the family of plant virus.
Currently over 360 species in this family, divided among 9 genera.
Diseases associated with this family include bright yellow mosaic , yellow mosaic, yellow mottle, leaf curling, stunting, streaks, reduced yields.
Ss circular dna diverge in both directions from a virion strand origin of replication (AMBISENSE).
Virus Classification:Group – Group II (ssDNA)
Order - Unassigned
Family - Geminiviridae
Genera – Becurtovirus Grablovirus
Begomovirus Mastrevirus
Capulavirus Topocuvirus
curtovirus Turncurtovirus
Eragrovirus
Structure: have Circular single-stranded DNA.
Genome is either in two segments.
The non-segmented genome is 2500-3000 nucleotides long, and the segmented genome is 4800-5600 nucleotides long.
The genome encodes for both structural and non-structural proteins.
In geminivirus, both segments must be transmitted to the host for a full systemic infection to occur.
Virion Sturcture:Geminivirus are non-enveloped, icosahedral virions that consists of a capsid.
The capsid is germinate, or twinned, and consists of 22 Capsomers.
The capsid is 30nm long and has a diameter of 18-20nm.
Symptoms:the time of infection, the virus strains and the presence of mixed infections.
Common symptoms are stunting, curling, and twisting of leaves.
Short internodes and stunted appearance , no apical growth caused by early infection.
Replication:Geminivirus encodes only a few proteins, thus they need to dependent host cell factors for replication.
These factors are DNA polymerase and repair polymerase to amplify their genome.
Replicate by a rolling circle mechanism like bacteriophages such as M13, and many plasmids.
Bacteriophage vectors
Bacteriophage
WHY BACTERIOPHAGE AS A VECTOR?
M13 phage
Genome of m13 phage
Life cycle and dna replication of m13
CONSTRUCTION M13 AS PHAGE VECTOR
M13 MP 2 vector
M13MP7 VECTOR
Selection of recombinants
Lambda replacement vectors
LAMBDA EMBL 4 VECTOR
P1 PHAGE
GENOME OF P1 PHAGE
P1 PHAGE AS VECTOR
P1 phage vector system
Introduction to Biotechnology in India-History and Evolution. Brief Discussion about Current scenario and scope of Biotechnology in India and top companies.
Introduction
Definition of an Insect Resistant Plant
What is the Bt gene?
History
The crystal ( cry)Proteins
Definition of cry protein
How does Bt work?
Mechanism of Bt toxicity
Mode of Action of Insecticidal Crystal Protein
Bt Technology
The Insect Resistance Problem
Advantages
Limitations
Conclusion
References
Bacteriophage vectors
Bacteriophage
WHY BACTERIOPHAGE AS A VECTOR?
M13 phage
Genome of m13 phage
Life cycle and dna replication of m13
CONSTRUCTION M13 AS PHAGE VECTOR
M13 MP 2 vector
M13MP7 VECTOR
Selection of recombinants
Lambda replacement vectors
LAMBDA EMBL 4 VECTOR
P1 PHAGE
GENOME OF P1 PHAGE
P1 PHAGE AS VECTOR
P1 phage vector system
Introduction to Biotechnology in India-History and Evolution. Brief Discussion about Current scenario and scope of Biotechnology in India and top companies.
Introduction
Definition of an Insect Resistant Plant
What is the Bt gene?
History
The crystal ( cry)Proteins
Definition of cry protein
How does Bt work?
Mechanism of Bt toxicity
Mode of Action of Insecticidal Crystal Protein
Bt Technology
The Insect Resistance Problem
Advantages
Limitations
Conclusion
References
this helps to understand the normal techniques related to biotechnology in a simple manner and provides you broad idea about the subject. A brief knowledge about the topic is presented in this presentation.
Biotechnology, scope, groups of organisms used biotechnology tools, red biotechnology, biologics:products of biotechnology,advantages and limitations of biotechnology, pharmaceuticals vs biologics, rDNA technology, manufacture of biologics, therapeutic biologics, recombinant vaccines, marketed biologics, biosimilars: Indian scenario
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...University of Maribor
Slides from:
11th International Conference on Electrical, Electronics and Computer Engineering (IcETRAN), Niš, 3-6 June 2024
Track: Artificial Intelligence
https://www.etran.rs/2024/en/home-english/
This presentation explores a brief idea about the structural and functional attributes of nucleotides, the structure and function of genetic materials along with the impact of UV rays and pH upon them.
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...Scintica Instrumentation
Intravital microscopy (IVM) is a powerful tool utilized to study cellular behavior over time and space in vivo. Much of our understanding of cell biology has been accomplished using various in vitro and ex vivo methods; however, these studies do not necessarily reflect the natural dynamics of biological processes. Unlike traditional cell culture or fixed tissue imaging, IVM allows for the ultra-fast high-resolution imaging of cellular processes over time and space and were studied in its natural environment. Real-time visualization of biological processes in the context of an intact organism helps maintain physiological relevance and provide insights into the progression of disease, response to treatments or developmental processes.
In this webinar we give an overview of advanced applications of the IVM system in preclinical research. IVIM technology is a provider of all-in-one intravital microscopy systems and solutions optimized for in vivo imaging of live animal models at sub-micron resolution. The system’s unique features and user-friendly software enables researchers to probe fast dynamic biological processes such as immune cell tracking, cell-cell interaction as well as vascularization and tumor metastasis with exceptional detail. This webinar will also give an overview of IVM being utilized in drug development, offering a view into the intricate interaction between drugs/nanoparticles and tissues in vivo and allows for the evaluation of therapeutic intervention in a variety of tissues and organs. This interdisciplinary collaboration continues to drive the advancements of novel therapeutic strategies.
Introduction:
RNA interference (RNAi) or Post-Transcriptional Gene Silencing (PTGS) is an important biological process for modulating eukaryotic gene expression.
It is highly conserved process of posttranscriptional gene silencing by which double stranded RNA (dsRNA) causes sequence-specific degradation of mRNA sequences.
dsRNA-induced gene silencing (RNAi) is reported in a wide range of eukaryotes ranging from worms, insects, mammals and plants.
This process mediates resistance to both endogenous parasitic and exogenous pathogenic nucleic acids, and regulates the expression of protein-coding genes.
What are small ncRNAs?
micro RNA (miRNA)
short interfering RNA (siRNA)
Properties of small non-coding RNA:
Involved in silencing mRNA transcripts.
Called “small” because they are usually only about 21-24 nucleotides long.
Synthesized by first cutting up longer precursor sequences (like the 61nt one that Lee discovered).
Silence an mRNA by base pairing with some sequence on the mRNA.
Discovery of siRNA?
The first small RNA:
In 1993 Rosalind Lee (Victor Ambros lab) was studying a non- coding gene in C. elegans, lin-4, that was involved in silencing of another gene, lin-14, at the appropriate time in the
development of the worm C. elegans.
Two small transcripts of lin-4 (22nt and 61nt) were found to be complementary to a sequence in the 3' UTR of lin-14.
Because lin-4 encoded no protein, she deduced that it must be these transcripts that are causing the silencing by RNA-RNA interactions.
Types of RNAi ( non coding RNA)
MiRNA
Length (23-25 nt)
Trans acting
Binds with target MRNA in mismatch
Translation inhibition
Si RNA
Length 21 nt.
Cis acting
Bind with target Mrna in perfect complementary sequence
Piwi-RNA
Length ; 25 to 36 nt.
Expressed in Germ Cells
Regulates trnasposomes activity
MECHANISM OF RNAI:
First the double-stranded RNA teams up with a protein complex named Dicer, which cuts the long RNA into short pieces.
Then another protein complex called RISC (RNA-induced silencing complex) discards one of the two RNA strands.
The RISC-docked, single-stranded RNA then pairs with the homologous mRNA and destroys it.
THE RISC COMPLEX:
RISC is large(>500kD) RNA multi- protein Binding complex which triggers MRNA degradation in response to MRNA
Unwinding of double stranded Si RNA by ATP independent Helicase
Active component of RISC is Ago proteins( ENDONUCLEASE) which cleave target MRNA.
DICER: endonuclease (RNase Family III)
Argonaute: Central Component of the RNA-Induced Silencing Complex (RISC)
One strand of the dsRNA produced by Dicer is retained in the RISC complex in association with Argonaute
ARGONAUTE PROTEIN :
1.PAZ(PIWI/Argonaute/ Zwille)- Recognition of target MRNA
2.PIWI (p-element induced wimpy Testis)- breaks Phosphodiester bond of mRNA.)RNAse H activity.
MiRNA:
The Double-stranded RNAs are naturally produced in eukaryotic cells during development, and they have a key role in regulating gene expression .
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Sérgio Sacani
We characterize the earliest galaxy population in the JADES Origins Field (JOF), the deepest
imaging field observed with JWST. We make use of the ancillary Hubble optical images (5 filters
spanning 0.4−0.9µm) and novel JWST images with 14 filters spanning 0.8−5µm, including 7 mediumband filters, and reaching total exposure times of up to 46 hours per filter. We combine all our data
at > 2.3µm to construct an ultradeep image, reaching as deep as ≈ 31.4 AB mag in the stack and
30.3-31.0 AB mag (5σ, r = 0.1” circular aperture) in individual filters. We measure photometric
redshifts and use robust selection criteria to identify a sample of eight galaxy candidates at redshifts
z = 11.5 − 15. These objects show compact half-light radii of R1/2 ∼ 50 − 200pc, stellar masses of
M⋆ ∼ 107−108M⊙, and star-formation rates of SFR ∼ 0.1−1 M⊙ yr−1
. Our search finds no candidates
at 15 < z < 20, placing upper limits at these redshifts. We develop a forward modeling approach to
infer the properties of the evolving luminosity function without binning in redshift or luminosity that
marginalizes over the photometric redshift uncertainty of our candidate galaxies and incorporates the
impact of non-detections. We find a z = 12 luminosity function in good agreement with prior results,
and that the luminosity function normalization and UV luminosity density decline by a factor of ∼ 2.5
from z = 12 to z = 14. We discuss the possible implications of our results in the context of theoretical
models for evolution of the dark matter halo mass function.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.Sérgio Sacani
The return of a sample of near-surface atmosphere from Mars would facilitate answers to several first-order science questions surrounding the formation and evolution of the planet. One of the important aspects of terrestrial planet formation in general is the role that primary atmospheres played in influencing the chemistry and structure of the planets and their antecedents. Studies of the martian atmosphere can be used to investigate the role of a primary atmosphere in its history. Atmosphere samples would also inform our understanding of the near-surface chemistry of the planet, and ultimately the prospects for life. High-precision isotopic analyses of constituent gases are needed to address these questions, requiring that the analyses are made on returned samples rather than in situ.
Seminar of U.V. Spectroscopy by SAMIR PANDASAMIR PANDA
Spectroscopy is a branch of science dealing the study of interaction of electromagnetic radiation with matter.
Ultraviolet-visible spectroscopy refers to absorption spectroscopy or reflect spectroscopy in the UV-VIS spectral region.
Ultraviolet-visible spectroscopy is an analytical method that can measure the amount of light received by the analyte.
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Ana Luísa Pinho
Functional Magnetic Resonance Imaging (fMRI) provides means to characterize brain activations in response to behavior. However, cognitive neuroscience has been limited to group-level effects referring to the performance of specific tasks. To obtain the functional profile of elementary cognitive mechanisms, the combination of brain responses to many tasks is required. Yet, to date, both structural atlases and parcellation-based activations do not fully account for cognitive function and still present several limitations. Further, they do not adapt overall to individual characteristics. In this talk, I will give an account of deep-behavioral phenotyping strategies, namely data-driven methods in large task-fMRI datasets, to optimize functional brain-data collection and improve inference of effects-of-interest related to mental processes. Key to this approach is the employment of fast multi-functional paradigms rich on features that can be well parametrized and, consequently, facilitate the creation of psycho-physiological constructs to be modelled with imaging data. Particular emphasis will be given to music stimuli when studying high-order cognitive mechanisms, due to their ecological nature and quality to enable complex behavior compounded by discrete entities. I will also discuss how deep-behavioral phenotyping and individualized models applied to neuroimaging data can better account for the subject-specific organization of domain-general cognitive systems in the human brain. Finally, the accumulation of functional brain signatures brings the possibility to clarify relationships among tasks and create a univocal link between brain systems and mental functions through: (1) the development of ontologies proposing an organization of cognitive processes; and (2) brain-network taxonomies describing functional specialization. To this end, tools to improve commensurability in cognitive science are necessary, such as public repositories, ontology-based platforms and automated meta-analysis tools. I will thus discuss some brain-atlasing resources currently under development, and their applicability in cognitive as well as clinical neuroscience.
Professional air quality monitoring systems provide immediate, on-site data for analysis, compliance, and decision-making.
Monitor common gases, weather parameters, particulates.
Role of biotechnology in the management of disease
1. Role of Biotechnology in The
Management of Disease
Gopal Jee Gopal, PhD(JNU)
Assistant Professor
C.G.Bhakta Institute of Biotechnology
Uka Tarsadia University, Bardoli
2. What is Biotechnology?
Using living organism or materials for commercial, industrial & healthcare
purpose(human welfare).
Biotechnology is the use of Biological processes, organisms or systems to
manufacture products intended to improve the quality of human life.
Gene manipulation technology/Recombinant DNA Technology/Gene cloning
has revolutionized biotechnology.
Gene: A gene is the basic functional unit of heredity.
Genes are segments of DNA and having information in the form of
nucleotide sequence which is decoded, when required, in the form of
mRNA /proteins.
Gene , directly or indirectly, is responsible for every character of an
organism.
3. 5’-ATGCCTAGGTACCTATGA-3’
3’-TACGGATCCATGGATACT-5’
5’-AUG CCU AGG UAC CUA UGA-3’
N-MET-PRO-ARG-TYR-LEU-C
DNA/gene
Transcription
Translation
mRNA
Protein
Flow of information coded in the gene
Basis of Gene Manipulation technology
* Codons and decoding pathways are almost universal.
4. Overview of recombinant DNA technology/Gene manipulation
Bacterial cell
Bacterial
chromosome Plasmid
Gene of interest
DNA containing
gene of interest
Isolate plasmid.
Enzymatically cleave DNA into fragments.
Isolate fragment
with the gene of
interest.
Ligate gene into plasmid.
Transform bacteria with ligated plasmid
Culture bacteria.
Harvest copies of gene to insert into
plants or animals
Harvest proteins coded by gene
5. Application of Gene Manipulation
Technology in the Management of
Diseases.
1. Nutritious food to overcome disease caused by nutrition
deficiency.
2. Prevention of Pathogenic Disease by Vaccination/
immunization
3. Diagnosis of Disease:
4. Treatment of Disease:
5. Understanding the new/unknown disease.
6. 1. How Biotechnology(Gene
Manipulation) helps in Providing
Nutritious food?
1. Golden Rice: a transgenic rice having high Vitamin A content.
Carotene( precursor of VitA) biosynthetic gene has been introduced
in paddy.
2. High iron Containing transgenic Banana:
Ferritin gene has been introduced.
3. Transgenic soya with high amount of Vit E.
7. 2. How Biotechnology helps in
Prevention of Disease?
Production of Different categories of vaccines: Vaccination is the
administration of antigenic material (Vaccine) to stimulate an
individual's immune system to develop immunity against pathogen.
Types of vaccine: Attenuated Vaccine , inactivated vaccine,
Subunit vaccine, DNA Vaccine etc.
11. 3. Biotechnology in Diagnosis of
Disease.
1. PCR based Diagnosis of disease: PCR, RT- PCR and Real time
PCR are used to diagnose diseases. Presence of bacteria/
virus can be detected at early stage of infection.
2. Antibody based Diagnosis of Disease: eg. ELISA,
Immunocytochemistry, immunohistochemistry, Western blotting based,
Radioimmuno assay, Immunoflourescence, immunoelectron microscopy etc.
3. DNA hybridization based diagnosis: Southern blotting, Northern
Blotting, FISH , DNA micro array etc.
4. DNA sequence based Diagnosis: Single Nucleotide
polymorphism. Gene sequencing, Finding triplet codon repeats
( huntington’s disease).
12. PCR based Diagnosis
Invitro amplification of a known ( at least terminal seq should be
known) DNA segments.
A. Increases quantity to million-billion times .
B. Amplify only specific sequence from mixture of DNA.
R.T PCR and Real time PCR are used to observe expression of gene/s so can
be used to observe presence of pathogenic RNA viruses too.
Virus load can also be quantified.
14. 4. Treatment of Diseases
A. Therapeutic Recombinant Proteins: Several human disorders are due to
absence of or malfunctioning of protein usually synthesized in the body.
Human proteins are produced in bacteria or other organism using recombinant
DNA technology
eg. Insulin (humulin), Growth hormone, blood clotting factor etc.
B. Therapeutic nucleic acid used for Gene Therapy:
Addition or deletion of gene which cause disease or mask the expression of
disease causing gene by antisense technology.
C. Therapeutic antibodies: Antibodies conjugated with toxin kills cancer
cell/tissue.
D. Antibiotics: Use to treat microbial disease. Antibiotics are secreted by
Microorganism but to increase yield or get modified version of antibiotics
scientists apply gene manipulation technology.
E. Biosynthesis and production of natural drugs are being increase applying
metabolic engineering. Eg. Vinblastine, vincristine etc.
16. B. Gene Therapy
This is a technique whereby a working gene replaces the absent or faulty gene,
so that the body can make the correct enzyme or protein and consequently
eliminate the root cause of the disease. Gene therapy may also used for curing
Cancer.
21. D.Impact of discovery of Antibiotics
It is estimated that penicillin has saved at least
200 million lives since its first use as a medicine in
1942.
22. E.Increasing Drug biosynthesis and
production by metabolic engineering.
• Removal of rate-limiting transcriptional and allosteric
controls.
• Kinetic enhancement of rate-limiting enzymes.
• Genetic inhibition of competing pathways.
• Enhanced carbon commitment to the primary metabolic
pathway from central metabolism.
• Modification of secondary metabolic pathways to
enhance energy metabolism and the availability
of enzymatic cofactors.
• Enhanced transport of the compound out of the
cell.
23. 5. To understand the cause and
Mechanism of Disease
1. Transgenic animals as models of Human disease:
We create diseased mice, rabbit by deletion or addition of gene to understand
the disease.
Ex: A.Creation of model of Alzheimer’s disease by overexpression of
Amyloid precursor Protein.
B. Creation of mouse model ( by knock out) for hypoxanthine-guanine
phosphoribosyltransferase (HPRT) deficiency.
C. Gene targeting has been widely used to model human cancers caused by the
inactivation ( Gene knock out) of Tumour suppressor genes such as TP53 and
RB1.
2. Finding the function/role of unknown gene: Knock out, knock down,
overexpression.
3. Pharmacogenomics: Role of genome in drug response.
It opens the field personalised medicine.
24. Summary
Gene manipulation technology in
Disease Management
1.Nutritious
food
Eg. Golden rice,
Iron containing
Banana.
2.Prevention
Immunization
eg. Vaccine against
pathogen
3. Diagnosis
Eg. PCR based ,
Blotting based
ELISA based
Western blotting
based.
4.Cure/treatment
Therapeutic proteins,
oligonucleotide
Antibodies and
Antibiotics.
5. Understanding
the disease:
Creation of diseased
Animal model.
Pharmacogenomics